APN 201802150014A
Trading Statement
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")
Trading Statement
Aspen shareholders are hereby advised that normalised headline earnings per share
(“NHEPS”), headline earnings per share and earnings per share for the 6 months ended
31 December 2017 are expected to improve on those reported in the comparative period
ended 31 December 2016, within the following ranges:
Measure Range Cents per share Cents per share in
the period -
31 December 2016
NHEPS 23% to 27% 851.2 to 878.8 692.0
Headline earnings per 28% to 32% 820.4 to 846.0 640.9
share
Earnings per share 27% to 31% 785.6 to 810.4 618.6
NHEPS comprises headline earnings per share adjusted for specific non-trading items.
NHEPS is the primary measure used by management to assess Aspen’s underlying
financial performance.
The financial results on which this trading announcement is based have not been reviewed
or reported on by Aspen’s external auditors.
Aspen’s results for the 6 months ended 31 December 2017 are scheduled to be published
on SENS on 8 March 2018.
Durban
15 February 2018
Sponsor: Investec Bank Limited
Date: 15/02/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS. |